Tenet Healthcare (THC) – Investment Analysts’ Weekly Ratings Changes

Several brokerages have updated their recommendations and price targets on shares of Tenet Healthcare (NYSE: THC) in the last few weeks:

• 10/17/2026 – Tenet Healthcare was upgraded by Wall Street Zen from “buy” to “strong-buy”.
• 10/16/2026 – Tenet Healthcare had its price target raised by Guggenheim from $283.00 to $307.00. They now have a “buy” rating on the stock.
• 10/8/2026 – Tenet Healthcare was upgraded by Weiss Ratings from “buy (b-)” to “buy (b)”.
• 10/3/2026 – Tenet Healthcare was downgraded by Wall Street Zen from “strong-buy” to “buy”.
• 10/2/2026 – Tenet Healthcare had its “overweight” rating reaffirmed by Cantor Fitzgerald.
• 9/29/2026 – Tenet Healthcare was downgraded by Zacks Research from “strong-buy” to “hold”.
• 9/22/2026 – Tenet Healthcare is now covered by BMO Capital Markets. They set a “market perform” rating and a $265.00 price target on the stock.
• 9/22/2026 – Tenet Healthcare is now covered by BMO Capital Markets. They set a “market perform” rating and a $265.00 price target on the stock.
• 9/18/2026 – Tenet Healthcare had its “outperform” rating reaffirmed by Leerink Partners. They now have a $309.00 price target on the stock.
• 8/23/2026 – Tenet Healthcare was upgraded by Wall Street Zen from “buy” to “strong-buy”.

Insider Activity

In related news, Director J. Robert Kerrey sold 12,010 shares of Tenet Healthcare stock in a transaction on Monday, September 14th. The shares were sold at an average price of $263.72, for a total value of $3,167,277.20. Following the completion of the sale, the director owned 4,794 shares in the company, valued at approximately $1,264,273.68. The trade was a 71.47% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Lisa Y. Foo sold 24,000 shares of the company’s stock in a transaction on Monday, August 31st. The shares were sold at an average price of $266.32, for a total transaction of $6,391,680.00. Following the completion of the sale, the executive vice president directly owned 8,053 shares in the company, valued at $2,144,674.96. This represents a 74.88% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 131,199 shares of company stock worth $35,065,587 over the last quarter. Corporate insiders own 0.97% of the company’s stock.

Tenet Healthcare Corp. (NYSE: THC) is a diversified healthcare services company headquartered in Dallas, Texas. Through its hospital operations and outpatient platforms, the company provides a range of medical services to patients across the United States.

Tenet operates acute care and specialty hospitals, ambulatory surgery centers, imaging facilities and other outpatient care sites. Its United Surgical Partners International subsidiary is a major provider of ambulatory surgery services and partners with physicians and health systems.